Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
natalizumab (tysabri) (1 trial)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Sclerosis (Phase 4)
Trials (1 total)
Trial APIs (1 total)